SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2016 Biotech Charity Contest
XBI 109.29+0.1%Nov 6 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
ghmm
The Ox
Thehammer
To: BulbaMan who wrote (263)12/9/2016 9:16:34 PM
From: BulbaMan3 Recommendations  Read Replies (2) of 311
 
ATTENTION BIOTECHIES: I assume, despite the less than stellar performance of most Contest portfolios in 2016, there’s still interest in a 2017 Biotech Charity Contest. Please let me know if my assumption is correct. Thanks, Bulba.

12/9/16 Contest update
Congress overwhelmingly approved the ‘‘21st Century Cures Act’’ last week but that wasn’t enough to cure the continued underperformance of biotech stocks. It may be biotech investors fear drugs will face competition from placebos if libertarian, Jim O’Neill, on Trump’s list for FDA chief, gets the job.
Meanwhile, at Friday’s close, the Contest median was down -24.54% YTD (vs. down -25.11% YTD a week ago). The Nasdaq Biotech Index (NBI) was down -20.39% YTD (vs. down -20.07% YTD a week ago), while the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was down -11.86% YTD (vs. down -11.98% YTD a week ago). The Nasdaq Composite Index (NCI) was up 8.73% YTD (vs. up 4.96% YTD a week ago).
JBOG’s portfolio, up 26.80% YTD, remained in the lead, with DNAJOE’s portfolio, up 21.30% YTD, still in second place and BIOPLAY’s’s portfolio, up 15.58% YTD, moving into third place.
At Friday’s close, 7 of the 58 Contest portfolios were in the green, with 24 portfolios beating the NBI and 16 beating the SPSIBI. The 223 Contest stock picks had an average YTD loss of -17.36% and a median YTD loss of -29.49%, with 53 of the 223 Contest portfolio stocks up for the year.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week, ranked by % Gained and % Lost. (Prices not converted to US$ in these Tables.)
Portfolio adjustments: None
(All corrections, especially adjustments for splits, greatly appreciated.)
Enjoy a safe & fun weekend biotechies.
Peace & good health,
Bulba

			12/9/16	
Rank Name Profit/Loss
1 JBOG 26,797
2 DNAJOE 21,302
3 BIOPLAY 15,578
4 STEVEL 13,743
5 BMAZ 5,047
6 USUBAN 3,880
7 THEOX 599
8 CEMBP -2,747
9 BAGEL -3,758
10 TOMP -4,372

Week's Top 5 Gainers
Symbol 12/2/16 12/9/16 Wk.%chg.
SSH 0.18 0.50 177.78%
MSTX 0.08 0.12 46.75%
TVIA 1.15 1.55 34.78%
PPHM 0.30 0.40 31.30%
EBS 26.27 32.37 23.22%

Week's Worst 5 Losers
Symbol 12/2/16 12/9/16 Wk.%chg.
GBIM 0.57 0.40 -29.82%
CAPR 3.200 2.670 -16.56%
RPRX 1.77 1.51 -14.69%
BLCM 18.72 16.05 -14.26%
CUR 0.27 0.24 -11.91%
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext